BioNexus KC Highlights Children's Mercy Researchers
The Kansas City region is a global leader at the nexus of human and animal health science. The mission of BioNexus KC is to "inspire thinkers from different disciplines to combine their efforts for a common purpose – healthcare innovation. From bioinformatics to cancer research and beyond, we stimulate collaboration and help bring emerging technologies from concept to reality."
The BioNexus Expert Exchange features regional researchers with advanced medical breakthroughs. Tom Curran, PhD, FRS, Executive Director of the Children's Research Institute at Children's Mercy and Mark Clements, MD, PhD, Endocrinology and Diabetes, are both featured in video interviews as part of the Expert Exchange series.
Mark Clements, MD, PhD
Technology-Enabled Pediatric Diabetes Management
Tom Curran, PhD, FRS
Children's Mercy Director Moving Kids with Brain Tumors to the Front of the Line
Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in nine specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services five consecutive times. With 386 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy also is nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.